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cardiac-related hospitalisations and all-cause deaths during 
a median follow-up of 3.9 years were obtained from pur-
pose-designed questionnaires and patients’ medical records.
Results Results of multivariable Cox regression analyses 
showed that poor patient-reported health status (KCCQ 
score < 50) prior to implantation was associated with a 2.5-
fold increased risk of cardiac hospitalisation or all-cause 
death, independent of sociodemographic, clinical and psy-
chological risk factors (adjusted hazard ratio 2.46, 95 % 
confidence interval (CI) 1.30–4.65). Poor health status was 
not significantly associated with the absolute number of car-
diac-related hospital admissions, but with the total number 
of days spent in hospital during follow-up (adjusted inci-
dence rate ratio 3.20, 95 % CI 1.88–5.44).
Conclusions Patient-reported health status assessed prior 
to CRT identifies patients at risk for poor survival and pro-
longed hospital stays, independent of traditional risk fac-
tors. These results emphasise the importance of incorporat-
ing health status measures in cardiovascular research and 
patient management. Heart failure patients reporting poor 
health status should be identified and offered appropriate 
additional treatment programs.
Keywords Heart failure · Cardiac resynchronisation 
therapy · Health status · KCCQ · Prognosis
Introduction
A large amount of research has been performed in search of 
factors predicting treatment outcomes in heart failure patients 
receiving cardiac resynchronisation therapy (CRT) [1], but 
the role of patient-reported factors has largely been neglected 
[2]. A recent meta-analysis showed that disease-specific 
health status assessed with the Kansas City Cardiomyopathy 
Abstract
Background Patient-reported factors have largely been 
neglected in search of predictors of response to cardiac re-
synchronisation therapy (CRT). The current study aimed to 
examine the independent value of pre-implantation patient-
reported health status in predicting four-year survival and 
cardiac-related hospitalisation of CRT patients.
Methods Consecutive patients (N = 139) indicated to re-
ceive a first-time CRT-defibrillator at the University Medi-
cal Center Utrecht were asked to complete a set of ques-
tionnaires prior to implantation. The Kansas City Cardio-
myopathy Questionnaire (KCCQ) was used to assess heart 
failure-specific health status. Data on patients’ demographic, 
clinical and psychological characteristics at baseline, and on 
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Questionnaire (KCCQ) or Minnesota Living with Heart Fail-
ure Questionnaire (MLHFQ) is a predictor of prognosis in 
heart failure patients, above and beyond traditional risk fac-
tors [3]. The PROSPECT (Predictors of Response to CRT) 
trial found that a five-point improvement on the KCCQ in 
the first 6 months of CRT was associated with a 15 % lower 
risk of all-cause mortality during 18 months of follow-up [4]. 
In accordance, a sub-study of the TRUST-CRT (Triple-Site 
versus Standard CRT) study showed that unimproved scores 
on the MLHFQ in the first 6 months of CRT decreased the 
probability of event-free survival by 2.2 times, independent 
of clinical and echocardiographic response [5]. In order to 
enhance risk stratification of heart failure patients indicated 
for CRT, it is important to know the prognostic value of 
patient-reported health status assessed prior to implantation.
The aim of the current study was to examine whether 
pre-implantation heart failure-specific health status is asso-
ciated with (1) a combined endpoint of first-time cardiac-
related hospital admission or all-cause death, (2) the total 
number of cardiac-related hospital admissions, and (3) the 
cumulative length of cardiac-related hospital stays, during a 
follow-up of 4 years after CRT implantation, independent of 
sociodemographic, clinical and psychological risk factors.
Methods
Study design and participants
The sample comprised heart failure patients receiving a 
first-time CRT-defibrillator at the University Medical Center 
Utrecht, the Netherlands between January 2009 and August 
2011. Patients participated in the PSYHEART-CRT (The 
Influence of PSYchological Factors on Health Outcomes in 
HEART Failure Patients Treated with Cardiac Resynchro-
nisation Therapy) study, a prospective, single-centre, obser-
vational study [6]. Exclusion criteria were age < 18 or > 85 
years, a history of psychiatric illness other than affective/
anxiety disorders, cognitive impairments, on the waiting 
list for heart transplantation and insufficient knowledge of 
the Dutch language. Eligible patients who provided written 
informed consent were asked to complete a set of standardised 
and validated questionnaires 1 day before implantation. The 
Medical Ethics Committee of the University Medical Cen-
ter Utrecht approved the study protocol. The study was con-
ducted in accordance with the Helsinki Declaration.
Measures
Demographic and clinical variables
Information on sociodemographic and clinical character-
istics was captured via purpose-designed questions in the 
questionnaire and/or from patient medical records. Details 
regarding the collection of data from electrocardiograms 
and echocardiography have been described before [6].
Patient-reported health status
The KCCQ was used to assess heart failure-specific health 
status [7]. The KCCQ is a 23-item self-report questionnaire 
that assesses the following dimensions: physical limitation, 
symptoms, social function, and quality of life [7]. These 
subscales can be combined into a single overall summary 
score, which is transformed into a score from 0–100. Poor 
health status is defined as a KCCQ score of < 50 points [3]. 
The KCCQ has good metric and applicability properties, 
interpretability and is most sensitive to change compared 
with other heart failure-specific health status instruments [7, 
8].
Psychological factors
Anxiety was assessed with the State Anxiety subscale of the 
State-Trait Anxiety Inventory (STAI-S). The STAI-S has 
shown to be a valid and reliable measure with a score of ≥ 40 
indicating probable clinical levels of anxiety [9]. Depres-
sion was measured using the Patient Health Questionnaire 
(PHQ-9) with the nine items mirroring the diagnostic criteria 
for major depressive disorder [10]. Patients who score ≥ 10 
points are considered to have clinically relevant depressive 
symptoms. The PHQ-9 has good reliability and validity in 
patients with heart failure [11]. Finally, the 14-item Type D 
Scale (DS14) was used to assess Type D personality, which 
is defined by a general propensity to experience increased 
negative emotions paired with the non-expression of these 
emotions in social interaction [12]. The DS14 consists of 
two subscales assessing negative affectivity and social inhi-
bition, respectively. Only those patients scoring high on 
both subscales according to a standardised cut-off score of 
≥ 10 are identified as having a Type D personality. The DS14 
is a valid and reliable scale with high test-retest reliability 
[12].
Prognostic endpoints
First, we looked at the combined endpoint of first admis-
sion to the cardiology department or all-cause death from 
the date of implantation (between January 2009 and August 
2011) until 25 February 2015. Hospital admissions for 
lead- or device replacements were excluded from analyses. 
As secondary endpoints, we examined the total number of 
cardiac-related hospitalisations and the total number of days 
that patients were hospitalised during follow-up. Of note, 16 
patients were censored due to loss to follow-up.
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First-time cardiac-related hospitalisation or all-cause death
During follow-up with a median of 3.9 years (interquartile 
range (IQR) = 1.4–4.8 years), 61 patients were admitted to 
the cardiology department (n = 43) or died without being 
admitted first (n = 18). The incidence proportion of first-time 
events was 55 % (27/49) in patients reporting poor health 
status and 38 % (34/90) in patients with good health status 
(p = 0.049). Unadjusted Cox regression analysis showed 
that poor pre-implantation health status was associated with 
an increased HR for first-time adverse events after CRT 
implantation (HR = 1.93, 95 % CI = 1.16–3.20, p = 0.01; 
Fig. 1). In adjusted Cox regression analysis (n = 129, 
Table 2), this association remained significant (adjusted 
HR = 2.46, 95 % CI = 1.30–4.65, p = 0.005). Regarding the 
covariates, only male sex was significantly associated with 
an increased HR for first-time adverse events (adjusted 
HR = 2.07, 95 % CI = 1.02–4.19, p = 0.04). Of note, when 
adding QRS > 150 ms, ischaemic aetiology, having a part-
ner and being employed to the model, poor health status and 
male sex remained the only significant associates of the pri-
mary endpoint.
Cumulative number of cardiac-related hospitalisations
The median number of cardiac-related hospital admis-
sions during follow-up was 0 (IQR = 0–1), with a median 
of 0 (IQR = 0–2) for patients with a poor health status and 
0 (IQR = 0–1) for patients reporting good health status prior 
to implantation. Unadjusted negative binomial regression 
analysis showed that the incident rate of hospital admis-
sions did not significantly differ between patients with poor 
versus good health status (IRR = 1.52, 95 % CI = 0.91–2.55, 
p = 0.12). No adjusted analyses were performed.
Cumulative length of cardiac-related hospital admissions
The median cumulative number of days spent in hospi-
tal due to a cardiac-related cause during follow-up was 0 
(IQR = 0–1). For patients reporting poor health status prior 
to implantation the median number was 0 (IQR = 0–10) 
and for patients with good health status the median was 0 
(IQR = 0–1) days. Unadjusted negative binomial regression 
analysis showed that the incidence rate of days was signifi-
cantly higher for patients with poor health status compared 
with patients reporting good health status (IRR = 2.54, 95 % 
CI = 1.74–3.70, p < 0.001). This effect remained significant 
in adjusted analysis (n = 123, Table 2) with IRR = 3.20, 95 % 
CI = 1.88–5.44, p < 0.001. Looking at the covariates, QRS 
duration > 150 ms, unhealthy lifestyle, having a partner and 
being employed were significantly associated with a lower 
incident rate of days in hospital.
Statistical analyses
Baseline characteristics of patients reporting poor versus 
good health status were compared using the Chi-square test 
(Fisher’s exact test when appropriate) for discrete variables 
and Student’s independent samples t-test or Mann-Whitney 
U test for continuous variables. Cox regression was done 
to examine the relation between pre-implantation health 
status and event-free survival. Negative binomial regres-
sion analyses were performed to examine the association 
between pre-implantation health status and the cumulative 
number and length of cardiac-related hospital admissions 
during follow-up.
Multivariate Cox and negative binomial regression 
analyses were done to adjust for a priori selected covari-
ates. First, we composed a prognostic risk score (EAARN 
score) including left ventricular ejection fraction < 22 %, 
age ≥ 70 years, atrial fibrillation, renal dysfunction (cre-
atinine > 120 µmol/l) and New York Heart Association 
(NYHA) class III/IV [13]. An EAARN score of ≥ 3 risk fac-
tors has been associated with a high risk of poor prognosis 
and impaired health status in CRT patients [14]. In the pri-
mary multivariate analyses, we adjusted for EAARN score 
≥ 3, male sex, chronic obstructive pulmonary disease and/
or diabetes, unhealthy lifestyle (i.e., low educational level, 
body mass index > 30, and/or smoking), and psychological 
distress according to questionnaires or psychotropic medi-
cation prescription [3, 6, 13, 15]. The Cox proportional haz-
ards assumptions were validated and we used the rule of ten 
events per variable to prevent overfitting the model. For the 
secondary endpoints, we included the same covariates plus 
pre-implantation QRS duration > 150 ms, ischaemic aetiol-
ogy, having a partner, and being employed in the multivari-
ate model [6, 15–17]. Hazard ratios (HRs) and incidence 
rate ratios (IRRs) with their corresponding 95 % confidence 
intervals (CIs) were reported. Analyses were performed 
using SPSS version 21.0 for Windows (SPSS Inc., Chicago, 
IL).
Results
Patient characteristics
In total, 156 patients receiving a CRT-defibrillator were 
screened for the PSYHEART-CRT study, of which 139 
(89 %) consented to participate and completed the baseline 
questionnaires. Of these patients, 49 (35 %) reported poor 
health status prior to implantation. Demographic, clinical 
and psychological characteristics of the total sample, and 
stratified by pre-implantation health status and event-free 
survival are shown in Table 1.
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diac-related hospital admission or all-cause death after CRT 
implantation. Looking at cardiac-related hospital admis-
sions, health status was not significantly associated with the 
absolute number of admissions, but with the total number 
of days spent in hospital during follow-up. On average, 
patients with a low pre-implantation KCCQ score spent 8.7 
days in hospital due to cardiac reasons, compared with 3.4 
days for patients reporting a good health status.
Discussion
This study examined the value of pre-implantation patient-
reported health status in predicting four-year morbidity and 
mortality in patients treated with CRT. Results showed that 
poor heart failure-specific health status (i.e., KCCQ sum-
mary score < 50) prior to implantation was independently 
associated with a 2.5-fold increased risk of first-time car-
Table 1 Baseline characteristics stratified by pre-implantation health status, and by cardiac-related hospitalisation or all-cause death during 
follow-up
Pre-implantation characteristic Total Poor health status Good health status p-value Event Event-free p-value
(n if ≥ 5 % missing values) (n = 139) (n = 49) (n = 90) (n = 61) (n = 78)
Sociodemographic
Age, mean (SD) 66 (10) 65 (10) 66 (11) 0.69 66 (10) 66 (10) 0.83
Male sex 97 (70) 28 (57) 69 (77) 0.02* 48 (79) 49 (63) 0.04*
Having a partner 113 (81) 37 (76) 76 (84) 0.20 46 (75) 67 (86) 0.12
Lower educationa 18 (13) 13 (27) 5 (6) <0.001*** 12 (20) 6 (8) 0.04*
Currently employed 30 (22) 6 (13) 24 (27) 0.06 8 (13) 22 (28) 0.04*
Clinical
Upgradeb 36 (26) 14 (29) 22 (24) 0.60 18 (30) 18 (23) 0.39
Ischaemic aetiology 68 (49) 29 (59) 42 (47) 0.16 31 (51) 37 (47) 0.69
NYHA class III/IV 110 (79) 47 (96) 63 (70) <0.001*** 53 (87) 57 (73) 0.05*
LVEF, mean (SD) 25 (9) 26 (8) 24 (9) 0.26 25 (9) 25 (8) 0.56
Atrial fibrillation (n = 130) 20 (16) 9 (20) 11 (13) 0.32 12 (24) 8 (10) 0.05*
QRS (ms), median (IQR), 
(n = 128)
160 
(140–180)
160 (150–180) 160 (140–180) 0.52 160 
(140–180)
160 (145–180) 0.76
History of VT/VF 26 (19) 10 (20) 16 (18) 0.70 14 (23) 12 (15) 0.26
Left bundle branch block 
(n = 111)
60 (54) 21 (60) 39 (51) 0.40 24 (55) 36 (54) 0.93
Diabetes mellitus 30 (22) 11 (22) 19 (21) 0.86 10 (16) 20 (26) 0.19
COPD 22 (16) 13 (27) 9 (10) 0.01* 12 (20) 10 (13) 0.27
Renal failurec 50 (36) 16 (33) 34 (38) 0.55 27 (44) 23 (30) 0.07
Body mass index, median (IQR) 26 (24–29) 27 (24–31) 26 (23–29) 0.08 26 (24–29) 25 (24–31) 0.72
Smoking 21 (15) 11 (22) 10 (11) 0.08 8 (13) 13 (17) 0.56
Cardiac medication
Amiodarone 17 (12) 6 (12) 11 (12) 1.0 8 (13) 9 (12) 0.78
ACE inhibitors/ARBs 126 (91) 43 (88) 83 (92) 0.39 58 (95) 68 (87) 0.11
Beta blockers 108 (78) 35 (71) 73 (81) 0.19 48 (78) 60 (77) 0.80
Digoxin 23 (17) 10 (20) 13 (14) 0.37 11 (18) 12 (15) 0.68
Diuretics 118 (85) 42 (86) 76 (84) 0.84 52 (85) 66 (85) 0.92
Statins 84 (60) 30 (61) 64 (60) 0.89 38 (62) 46 (59) 0.69
Psychological functioning
Anxiety (STAI-S ≥ 40) 59 (43) 34 (71) 25 (28) < 0.001*** 24 (40) 35 (45) 0.52
Depression (PHQ-9 ≥ 10) 32 (23) 25 (51) 8 (9) < 0.001*** 17 (28) 16 (21) 0.31
Type D personality 32 (23) 20 (41) 12 (14) < 0.001*** 11 (18) 21 (27) 0.20
Psychotropic medication 33 (24) 18 (37) 15 (17) 0.008** 17 (28) 16 (21) 0.31
Data are presented as n(%), unless otherwise stated.
ACE angiotensin-converting enzyme, ARB angiotensin II receptor blockers, COPD chronic obstructive pulmonary disease, IQR interquartile 
range, LVEF left ventricular ejection fraction; ms milliseconds, NYHA New York Heart Association, PHQ-9 9-item Patient Health Questionnaire, 
SD standard deviation, STAI-S Stait-Trait Anxiety Inventory–State form; VT/VF ventricular tachycardia/fibrillation.
aPrimary school or lower.
bUpgrade from another implantable device, either (biventricular) pacemaker or implantable cardioverter defibrillator without cardiac 
resynchronisation therapy.
cRenal failure = creatinine > 120 µmol/L.
*p ≤ 0.05; ** p ≤ 0.01; ***p ≤ 0.001.
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Besides poor health status, male sex was independently 
associated with a higher risk of hospitalisation or death. 
This finding confirms a recent meta-analysis showing that 
women obtain greater reduction in risk of death, hospitali-
sation for heart failure and ventricular arrhythmias with 
CRT than men [24]. There was no independent associa-
tion between sex and the total length of hospital stays, but 
we did find that patients with a QRS duration of > 150 ms 
spend less days in hospital. Accordingly, a meta-analysis 
of six randomised clinical trials has demonstrated that the 
benefit of CRT appears to be most profound in patients with 
a pre-implantation QRS duration wider than 150 ms [25]. 
Looking at sociodemographic factors, having a partner and 
being employed were associated with a reduced number of 
admitted days. Previous studies in heart failure patients also 
found a correlation between partner status and risk of read-
mission and suggested that the lack of a social support sys-
tem at home might condemn patients to be admitted sooner 
and longer [26]. In addition, the current and previous results 
from a study in ischaemic heart disease patients showed 
that being employed is independently associated with a 
shorter total length of hospital stay during follow-up [16]. 
An explanation for this association might be that employed 
patients are concerned about missing work due to illness, 
making them wait longer before going to the hospital [27]. 
The current results underline that the routine assess-
ment of patient-reported health status is essential for clini-
cal evaluation and risk stratification of heart failure patients 
[18, 19]. Measures such as the KCCQ add valuable informa-
tion to what is routinely obtained during clinic visits, as they 
are only marginally associated with traditional measures 
of heart failure severity and treatment response, including 
physician-rated NYHA class [6, 20, 21]. The NYHA clas-
sification system has been criticised due to the method not 
being standardised making it poorly reproducible with high 
inter-rater variation, especially when differentiating patients 
belonging to class II versus III [22]. The KCCQ on the other 
hand has a clear cut-off point with a summary score of < 50 
indicating poor health status, which was demonstrated to be 
independently associated with a 1.5–2 point increased risk 
of morbidity and mortality in a broad range of heart failure 
patients [3], now including those receiving CRT. Regarding 
serial health status assessments, a mean change of ≥ 5 points 
in the KCCQ summary score has been associated with a 
9 % change in the adjusted HR for death in ischaemic heart 
failure patients [23], and 15 % in CRT patients [4]. It could 
be hypothesised that patients reporting a poor KCCQ score 
prior to implantation, which does not improve during the 
first months of CRT, have the worst prognosis; this should 
be investigated in future studies.
KEY MESSAGE   The prognostic value of patient-reported health status advocates its use in routine clinical practice.
Cumulative event-free survival curves by pre-implantation KCCQ score
Figure 1
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training of physicians to use these measures in clinical deci-
sion-making [29], particularly for therapies associated with 
trade-offs between improved quality of life and prolonged 
survival [30]. Once patients with poor health status are identi-
fied, they should be offered appropriate interventions in order 
to improve their quality of life and prognosis. Aerobic exer-
cise training and/or cognitive behavioural therapy have been 
shown to improve outcomes in heart failure and implantable 
cardioverter defibrillator patients [31–34]. But the number of 
studies is small and they suffer from methodological limita-
tions [33, 34]. Large-scale intervention trials are warranted 
to increase our knowledge on how and when to offer behav-
ioural intervention programmes in cardiac practice.
The major limitation of this study is it being a single-cen-
tre study with a relatively small sample size and low number 
of events. However, strengths of this study comprise the fol-
low-up period of 4 years, the use of a heart failure-specific 
health status measure and the adjustment for clinical, as well 
as sociodemographic and psychological characteristics.
In conclusion, the current study adds to the literature 
advocating routine use of instruments such as the KCCQ, 
which provide a quick and highly interpretable assessment 
of patient-perceived symptoms of heart failure, functional 
limitations and quality of life. They capture what is impor-
tant to patients and provide simple and significant indicators 
of prognosis and outcomes of heart failure treatments such 
as CRT, above and beyond traditional risk factors.
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